AKARI THERAPEUTICS PLC ADS news, videos and press releases
For more news please use our advanced search feature.
AKARI THERAPEUTICS PLC ADS - More news...
AKARI THERAPEUTICS PLC ADS - More news...
-
Akari Therapeutics, Plc - AKTX Stock Chart Technical Analysis for 01-10-2020
-
Akari Therapeutics, Plc - AKTX Stock Chart Technical Analysis for 12-02-2019
-
Akari Therapeutics, Plc - AKTX Stock Chart Technical Analysis for 08-29-2019
-
Akari Therapeutics, Plc - AKTX Stock Chart Technical Analysis for 08-14-2019
-
Akari Therapeutics, Plc - AKTX Stock Chart Technical Analysis for 04-23-2019
-
Akari Therapeutics, Plc - AKTX Stock Chart Technical Analysis for 03-14-2019
- Thinking about buying stock in Akari Therapeutics, Presbia Plc, Roku Inc., Snap Inc., or Pareteum Corp.?
-
Akari Therapeutics, Plc - AKTX Stock Chart Technical Analysis for 03-13-2019
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akari Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - AKTX
- EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Akari Therapeutics, Plc - AKTX
- AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc - (AKTX)
- URGENT: Monteverde & Associates PC Invites Akari Therapeutics, Plc. Shareholders with Significant Losses To Contact The Firm Immediately - AKTX
- Investor Alert: Kaplan Fox Announces Investigation Of Akari Therapeutics, PLC
- IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm
- AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm
- IMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm
- IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm
- SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017
- SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akari Therapeutics Plc (AKTX)
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akari Therapeutics plc - AKTX
- AKARI INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akari Therapeutics, Plc To Contact The Firm
- Edison Investment Research Issues Statement on Akari Therapeutics' statements and SEC Filing citing Edison
-
Akari Therapeutics
- Akari Therapeutics to Attend Upcoming Investor Conferences in February
- Akari Therapeutics Expands Clinical and Regulatory Teams with Industry Veterans
- Akari Therapeutics Announces FDA Allowance of IND for Clinical Development of Coversin in PNH
- Akari Therapeutics Announces Corporate Update with New Positive Clinical Data and a New Pipeline of Tick Derived and Engineered Proteins
- Akari Therapeutics to Attend Upcoming Investor Conferences In November
- Akari Therapeutics to Present Abstract on Potential Once Weekly PAS-Coversin at the 58th Annual Meeting of the American Society of Hematology
- Akari Therapeutics Appoints New Members to its Board of Directors
